IPP Bureau

Amaris Clinicals clears U.S. FDA audit
Amaris Clinicals clears U.S. FDA audit

By IPP Bureau - September 24, 2021

The company is the Clinical Research Organisation of Caplin Point Laboratories

Aurobindo subsidiary submits MAA for oncology biosimilar
Aurobindo subsidiary submits MAA for oncology biosimilar

By IPP Bureau - September 23, 2021

CuraTeQ Biologics is on track for filing a second oncology biosimilar

Roche launches three respiratory test panels on Cobas 6800/8800 Systems in CE markets
Roche launches three respiratory test panels on Cobas 6800/8800 Systems in CE markets

By IPP Bureau - September 23, 2021

Three new molecular diagnostic test panels for influenza and other common respiratory illnesses can be run together or alone using one patient sample

Thermo Scientific introduces the NanoDrop Eight UV-Vis spectrophotometer
Thermo Scientific introduces the NanoDrop Eight UV-Vis spectrophotometer

By IPP Bureau - September 23, 2021

The NanoDrop Eight simultaneously evaluates eight samples in 20 seconds or less and the instrument can also measure high-concentration samples of up to 200 absorbance units without dilution

Pfizer and BioNTech receive U.S. FDA EUA for Covid-19 booster
Pfizer and BioNTech receive U.S. FDA EUA for Covid-19 booster

By IPP Bureau - September 23, 2021

Emergency Use Authorisation (EUA) is granted for individuals 65 years of age and older, and individuals ages 18 through 64 within certain high-risk groups

Lonza to expand its drug manufacturing network in Switzerland
Lonza to expand its drug manufacturing network in Switzerland

By IPP Bureau - September 23, 2021

Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, has announced it will invest in additional drug product manufacturing capabilities in Switzerland

UFlex joins Alliance in its mission to end plastic waste
UFlex joins Alliance in its mission to end plastic waste

By IPP Bureau - September 23, 2021

UFlex has committed close to US $ 10 million towards various initiatives at its overseas and Indian plants to repurpose plastic waste

Endimension receives Rs 2.3 crore in seed funding
Endimension receives Rs 2.3 crore in seed funding

By IPP Bureau - September 23, 2021

The startup’s AI platform uses AI algorithms to automatically detect abnormalities and diseases in medical images, reducing patient misdiagnosis and increasing radiologists’ productivity

Indian Pharma Market growth stable in August 2021
Indian Pharma Market growth stable in August 2021

By IPP Bureau - September 23, 2021

Post normalisation of high growth months of April and May this year the average IPM growth from June to August this year stood at 15.2 % YoY : Ind-Ra reports

MergerDomo facilitates fundraising for health food and wellness startups
MergerDomo facilitates fundraising for health food and wellness startups

By IPP Bureau - September 22, 2021

The two startups will utilise the capital for business growth including strategic expansion, product development, R&D and technology investments

Terumo India releases stamp to commemorate the centenary of Terumo Corporation
Terumo India releases stamp to commemorate the centenary of Terumo Corporation

By IPP Bureau - September 22, 2021

Terumo’s first product was the domestically produced, safe, high-quality thermometer. The company has since supported the healthcare ecosystem worldwide

Boehringer Ingelheim acquires Abexxa Biologics to advance its cancer research
Boehringer Ingelheim acquires Abexxa Biologics to advance its cancer research

By IPP Bureau - September 22, 2021

The addition of Abexxa’s expertise complements Boehringer Ingelheim’s current approaches to the treatment of difficult-to-treat solid cancers and especially those resistant to available immunotherapies

SCHOTT expands tubing capacity in India
SCHOTT expands tubing capacity in India

By IPP Bureau - September 22, 2021

In India, almost all approved vaccines are packed in FIOLAX glass made by SCHOTT

Trialbee and Castor partner to simplify enrolment to clinical trials globally
Trialbee and Castor partner to simplify enrolment to clinical trials globally

By IPP Bureau - September 22, 2021

Industry leaders to increase patient access to clinical research and scale remote enrollment of participants for trial sponsors to promote increased health equity

DCGI approves Ampio Pharma’s Phase II trials to tackle Covid-19 induced respiratory distress
DCGI approves Ampio Pharma’s Phase II trials to tackle Covid-19 induced respiratory distress

By IPP Bureau - September 22, 2021

Ampion is directly administered by inhalation and it allows the drug to directly target and attenuate inflammation in the lungs

Latest Stories

Interviews

Packaging